BSEBoard Meeting3d ago · 3 Aug 2026, 12:32 pm
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
iSERA Lifesciences Ltd · 534920
✦ AI SummaryResults
iSERA Lifesciences Ltd has scheduled a Board Meeting on 07/08/2026 to consider and approve the unaudited financial results for the quarter ended 30/06/2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 7, August 2026 Inter-Alia, To Consider, Approve And Take On Record The Unaudited Financial Results Of The Company For The Quarter Ended On June 30, 2026
Attachments (1)
📄pdf
Download →
d8380fd9-2de5-4403-9706-db55f8b7ae6e.pdf
View document text
iSERA LIFESCIENCES
LIMITED
(Formerly known as Covidh Technologies Limited)
CIN: L72200PN1993PLC252720
Date: 03.08.2026
The Listing Department
BSE Limited,
25th Floor, Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai, Maharashtra – 400001
REF: iSERA Lifesciences Limited (Formerly Known as Covidh Technologies Limited)
(Scrip Code: 534920) | Symbol: COVIDH)
SUBJECT:
1. Information under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 regarding consideration of the Standalone Un-Audited Financial Results for
the quarter and year ended on June 30, 2026.
2. The SEBI (Prohibition of Insider Trading) Regulations, 2015 - Closure of Trading Window
announced with effect from June 01, 2026 until completion of 48 hours after declaration of the
Un-Un-Audited Financial Results of the Company for the quarter and year ended on June 30,
2026
Dear Sir/Madam,
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice
is hereby given that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 7,
August 2026 inter-alia, to consider, approve and take on record the Un-Audited Financial Results of the
Company for the quarter ended on June 30, 2026
Further, in terms of provisions of SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the
Trading Window for dealing in the Equity Shares of the Company shall remain closed for all designated persons,
for the period from, Wednesday July 01, 2026 and end 48 hours after the results are made public for the quarter
and year ended on June 30, 2026.
The said notice may be accessed on the Company’s website at https://covidhtechnologies.com
and may also be accessed on the Stock Exchanges website at https://bseindia.com
You are requested to please take on record our above said information for your reference.
Thanking you.
Yours faithfully,
For and on behalf of
iSERA Lifesciences Limited (Formerly Known as Covidh Technologies Limted)
Deepakshi
Company Secretary and Compliance Officer
M. No. 76335
Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001
Tel: +91 83290 12053 • Email: cscovidh@gmail.com • Website: www.covidhtechnologies.com